Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study

The treatment is already approved in the US for three disease states of prostate cancer

- PMLiVE

2023 PM Society Awards – winners announced

21GRAMS takes four Golds plus Best in Show AstraZeneca tops the pharma leader board

Next congress, please: making the most of virtual pharmaceutical congresses

By Aaron Hall

- PMLiVE

Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray

Royalty Pharma signed a deal for the programme in 2020 with Biohaven, which Pfizer has since acquired

- PMLiVE

Alzheimer’s Association report highlights need to improve patient-physician communication

Both individuals and primary care physicians reported a reluctance to address cognitive concerns

- PMLiVE

ABPI welcomes new NHS research guidance for integrated care systems

Included in the proposals are calls for a fixed rebate rate of 6.88% on all eligible NHS medicine sales to be paid by the industry

- PMLiVE

Congress is in session – how companies are boosting their impact and engagement

In-person conferences are back, but there is an urgency to reach a more diverse, inclusive audience through dynamic programmes and immersive technology

- PMLiVE

The challenges of reimbursement and innovative pricing for cell and gene therapies

Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...

Avalere Health

- PMLiVE

Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...

Avalere Health

VR/AR Applications for Training and Healthcare

In this episode of Impetus Digital's Fireside Chat, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Mike Waldron, who is the CEO and Co-Founder of Propel VR....

Impetus Digital

- PMLiVE

Medscape’s Commitment to Health Equity and Women’s Health

Women's health is a topic of increasing importance and interest among the medical community. Beyond impacting the individual patient, women's health is a public health issue in communities around the...

Medscape Education

- PMLiVE

US government announces first set of drugs subject to Medicare inflation rebates

The move could reduce out-of-pocket costs for Medicare beneficiaries by up to $390 per dose

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links